Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.
Kirova YM, Stoppa-Lyonnet D, Savignoni A, Sigal-Zafrani B, Fabre N, Fourquet A; Institut Curie Breast Cancer Study Group. Kirova YM, et al. Among authors: savignoni a. Eur J Cancer. 2005 Oct;41(15):2304-11. doi: 10.1016/j.ejca.2005.02.037. Epub 2005 Sep 1. Eur J Cancer. 2005. PMID: 16140006
Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first.
Bollet MA, Sigal-Zafrani B, Mazeau V, Savignoni A, de la Rochefordière A, Vincent-Salomon A, Salmon R, Campana F, Kirova YM, Dendale R, Fourquet A. Bollet MA, et al. Among authors: savignoni a. Radiother Oncol. 2007 Mar;82(3):272-80. doi: 10.1016/j.radonc.2007.01.001. Epub 2007 Feb 6. Radiother Oncol. 2007. PMID: 17287037
Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study.
Bollet MA, Thibault F, Bouillon K, Meunier M, Sigal-Zafrani B, Savignoni A, Diéras V, Nos C, Salmon R, Fourquet A; Institut Curie Breast Cancer Study Group. Bollet MA, et al. Among authors: savignoni a. Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):13-8. doi: 10.1016/j.ijrobp.2007.02.020. Epub 2007 Apr 20. Int J Radiat Oncol Biol Phys. 2007. PMID: 17449193 Clinical Trial.
Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy.
Kirova YM, Campana F, Savignoni A, Laki F, Muresan M, Dendale R, Bollet MA, Salmon RJ, Fourquet A; Institut Curie Breast Cancer Study Group. Kirova YM, et al. Among authors: savignoni a. Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):76-81. doi: 10.1016/j.ijrobp.2008.11.005. Epub 2009 Jan 23. Int J Radiat Oncol Biol Phys. 2009. PMID: 19168297
Urokinase-type plasminogen activator and plasminogen-activator-inhibitor type 1 predict metastases in good prognosis breast cancer patients.
De Cremoux P, Grandin L, Diéras V, Savignoni A, Degeorges A, Salmon R, Bollet MA, Reyal F, Sigal-Zafrani B, Vincent-Salomon A, Sastre-Garau X, Magdelénat H, Mignot L, Fourquet A; Breast Cancer Study Group of the Institut Curie. De Cremoux P, et al. Among authors: savignoni a. Anticancer Res. 2009 May;29(5):1475-82. Anticancer Res. 2009. PMID: 19443353 Free article.
Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment.
Bollet MA, Savignoni A, De Koning L, Tran-Perennou C, Barbaroux C, Degeorges A, Sigal-Zafrani B, Almouzni G, Cottu P, Salmon R, Servant N, Fourquet A, de Cremoux P. Bollet MA, et al. Among authors: savignoni a. Breast Cancer Res. 2009;11(4):R54. doi: 10.1186/bcr2343. Epub 2009 Jul 28. Breast Cancer Res. 2009. PMID: 19638208 Free PMC article.
95 results